ALS News Today10h
US trial of noninvasive ALS device gets green light to enroll patients
A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...
News-Medical.Net2d
Living in disadvantaged areas reduces ALS survival time by over 30%
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a Michigan Medicine-led study suggests.
Coya Therapeutics Now Pivots Toward Phase 2 In ALS And FTD
Financial writer discusses Coya Therapeutics, Inc.'s Treg therapies for neurodegenerative diseases like ALS, FTD, and PD.
ALS survival may be cut short by living in disadvantaged communities
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, ...